Search

everythinglearnresearchcommunity

for

Search:↓

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Polarized microscopy is a quick and free method to correctly identify types of hair loss.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

The botanical shampoo with Morus alba root extract is safe and effective for treating hair loss.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

Hair transplant and applying 5% minoxidil solution can effectively treat permanent hair loss, but it may change hair direction in some cases.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

The woman was diagnosed with lichen planopilaris and can be treated with corticosteroids.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.